Ajanta Pharma Ltd - Share Price
AJANTPHARM
Ajanta Pharma LtdFinancials
Ajanta Pharma LtdNews & Updates
Jun 04,2021 10:55 AM
On 14 July 2021
Ajanta Pharma grants 3000 stock options under ESOP Apr 30,2021
Ajanta Pharma consolidated net profit rises 23.30% in the March 2021 quarter Apr 30,2021
Ajanta Pharma to announce Quarterly Result Apr 21,2021
Ajanta Pharma consolidated net profit rises 64.23% in the December 2020 quarter Feb 02,2021
Ajanta Pharma to declare Quarterly Result Jan 23,2021
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 672.25 | 71.55 | 159,483.80 | 327.39 | 1.13 | 3,119.04 | 104.36 |
| Divis Laboratories Ltd | 4,248.75 | 57.72 | 112,813.53 | 487.93 | 0.47 | 1,718.39 | 349.25 |
| Dr Reddys Laboratories Ltd | 5,309.30 | 40.16 | 87,807.45 | 311.50 | 0.47 | 3,313.50 | 1,020.99 |
| Cipla Ltd | 957.10 | 31.05 | 76,657.20 | 413.41 | 0.53 | 3,173.39 | 247.09 |
| Cadila Healthcare Ltd | 624.00 | 38.80 | 63,236.58 | 464.70 | 0.57 | 1,949.70 | 124.49 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Ajanta Pharma LtdSummary & Reports
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. The company produces a comprehensive range of specialty products targeting different therapeutic segments. The companys business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. The branded... More
Registered Office
Ajanta House,Charkop Kandivli (W),Mumbai, Maharashtra,400067
Tell. : +91-22-66061000/1204/1203
Website : http://www.ajantapharma.com
Email : info@ajantapharma.com
Registrar Office
C-101 247 Park, Vikhroli West, Mumbai-400083 INDIA
Tell. : +91-22-49186000
Website : www.linkintime.com
Email : rnt.helpdesk@linkintime.co.in
Reports by ajanta-pharma-ltd-share-price
Latest Release by ajanta-pharma-ltd-share-price
Result Express
Jun 25, 2021 06:19 PM
The company’s consolidated revenue in the quarter stood at Rs485.11cr, down 17.36% yoy and 10.84% qoq.
Shareholding Snapshot
Loading ...
| Mar - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 70.34% |
| Total Promoter | 70.34% |
| Non Promoter | - |
| Institutions | 20.98% |
| Non-Institutions | 8.67% |
| Total Non-Promoter | 29.66% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
30 Apr 2021
Annc. Date
21 Apr 2021
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sche... More
Purpose
Board Meeting
Exp. Date
02 Feb 2021
Annc. Date
23 Jan 2021
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sche... More
